Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 3,205 | 2,947 | 802 | 802 | 802 |
| Gross Profit | 3,205 | 2,947 | 802 | 802 | 802 |
| Operating Expenses | 10,480 | 10,320 | 35,296 | 33,664 | 29,109 |
| Operating Income | -7,275 | -7,373 | -34,494 | -32,862 | -28,307 |
| Other Income | 1,468 | 535 | 98 | -910 | -887 |
| Pre-tax Income | -5,807 | -6,838 | -34,396 | -33,772 | -29,194 |
| Income Tax | N/A | N/A | -101 | -46 | -105 |
| Net Income Continuous | -5,807 | -6,838 | -34,295 | -33,726 | -29,089 |
| Net Income | $-5,807 | $-6,838 | $-34,295 | $-33,726 | $-29,089 |
| EPS Basic Total Ops | -16.69 | -19.84 | -10.79 | -10.61 | -9.17 |
| EPS Basic Continuous Ops | -16.69 | -19.84 | -10.81 | -10.56 | -9.12 |
| EPS Diluted Total Ops | -16.69 | -19.84 | -10.43 | -10.61 | -9.17 |
| EPS Diluted Continuous Ops | -16.69 | -19.84 | -10.52 | -10.56 | -9.12 |
| EBITDA(a) | $-7,126 | $-7,221 | $-35,273 | $-33,322 | $-28,108 |